logo

Intraday Alerts

Share

Xenetic Biosciences Inc. (XBIO) has been rising sharply since the open of trade Thursday and is now up 2.51 at $4.90 on above average volume. Xenetic Biosciences is adding to yesterday's gains and has surged to a new high for the year.

Steelcase Inc. (SCS) reported first quarter EPS of $0.14 after the bell Wednesday, down from $0.15 a year ago. The consensus estimate was for EPS of $0.28. Steelcase gapped open sharply lower Thursday morning and is now down 0.90 at $14.65. The stock has fallen to a 2-week low.

CASI Pharmaceuticals Inc. (CASI) announced Thursday morning that it has entered into a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical for entecavir and cilostazol. CASI Pharmaceuticals gapped open sharply higher Thursday, but has pared its gains in...

Stellar Biotechnologies Inc. (SBOT) announced Thursday morning that it has completed a research study focused on the molecular composition of its KLH products. Stellar Biotechnologies gapped open higher this morning and is now up 1.35 at $3.00 on above average volume. The stock has jumped to nearly a 1-month high.

Darden Restaurants Inc. (DRI) reported fourth quarter adjusted EPS of $1.39 Thursday morning, which topped the consensus estimate of $1.35. Darden Restaurants has gapped open sharply higher this morning and is now up 9.29 at $102.56 on above average volume. The stock has broken out to a new high for the year.

Kroger Co. (KR) reported first quarter adjusted EPS of $0.73 Thursday morning, which topped the consensus estimate of $0.63. Kroger gapped open sharply higher Thursday morning and is now up 2.89 at $29.07 on above average volume. The stock has jumped to a 4 1/2 month high.

Heron Therapeutics Inc. (HRTX) announced Thursday morning that it has received Breakthrough Therapy designation from the FDA for HTX-011, for postoperative pain management. Heron Therapeutics gapped open sharply higher Thursday morning and is now up 8.35 at $39.05 on above average volume. The stock...

La-Z-Boy Inc. (LZB) reported fourth quarter EPS of $0.72 after the bell Tuesday, compared to $0.57 a year ago. The consensus estimate was for EPS of $0.64. Revenues rose 1.8% to $420.03 million from $412.71 million last year. Analysts expected revenues of $427.4 million. La-Z-Boy gapped open lower...

Anika Therapeutics Inc. (ANIK) announced after the bell Tuesday that its Phase 3 study of CINGAL 16-02 in patients with knee osteoarthritis failed to reach statistical significance in terms of the primary endpoint. Anika Therapeutics gapped open sharply lower Wednesday morning and is now down 15.19...

Actuant Corp. (ATU) reported third quarter adjusted EPS of $0.39 Wednesday morning, which topped the consensus estimate of $0.36. Actuant has risen sharply in early trade Wednesday and is now up 1.35 at $27.30. The stock is now challenging the highs of the year, trading at a 6-month high.

Twenty-First Century Fox (FOX, FOXA) announced Tuesday morning that it has entered into an amended merger agreement with Walt Disney (DIS). Disney has agreed to acquire the company for $38 per share, up from the previous price of $28 per share. Twenty-First Century Fox gapped open sharply higher Tuesday...

Winnebago Industries Inc. (WGO) reported third quarter EPS of $1.02 Wednesday morning, up from $0.61 in the prior year period. Analysts expected EPS of $0.91. Winnebago gapped open sharply higher Wednesday morning and is now up 3.70 at $44.05. The stock has broken out to a 3-month high.

Caladrius Biosciences Inc. (CLBS) announced Tuesday that it has received a regenerative medicine advanced therapy designation from the FDA for its CD34+ cell therapy program for the treatment of refractory angina. Caladrius Biosciences has gapped open sharply higher Wednesday morning and is now up...

Neptune Technologies & Bioresources (NEPT) announced Tuesday morning that it has entered into a multi-year agreement to provide extracted cannabis products to Canopy Growth (WEED.TO). Neptune Technologies & Bioresources gapped open sharply higher this morning and is now up 0.67 at $3.12 in early trade....

Roche announced Tuesday morning that it has agreed to acquire the remaining shares of Foundation Medicine Inc. (FMI) that it does not already own for US$137.00 per share in cash. Foundation Medicine has gapped open sharply higher Tuesday morning and is now up 30.45 at $136.90 on strong volume. The...

Follow RTT